Page 1 of Clinical Trials for "Rifampin", 179 Total Matches
- 1Active, not recruitingLast Updated: July 27, 2010Condition(s): Alzheimer's Disease
- 2CompletedLast Updated: June 9, 2011Condition(s): Tuberculosis
- 3CompletedLast Updated: December 21, 2011Condition(s): Infection, Human Immunodeficiency Virus
- 4RecruitingLast Updated: May 21, 2012Condition(s): Infection
- 5RecruitingLast Updated: February 3, 2009Condition(s): Alzheimer's Disease
- 6CompletedLast Updated: June 4, 2011Condition(s): Lymphoma, Including Chronic Lymphocytic Leukemia; Solid Tumors
- 7RecruitingLast Updated: June 18, 2009Condition(s): HIV Infection; Tuberculosis
- 8RecruitingLast Updated: July 12, 2011Condition(s): Pulmonary Tuberculosis (TB)
- 9CompletedLast Updated: January 24, 2011Condition(s): Alzheimer Disease
- 10RecruitingLast Updated: March 2, 2012Condition(s): Prosthesis-related Infections; Staphylococcal Infections
- 11CompletedLast Updated: March 3, 2009Condition(s): Pharmacokinetics of YM178
- 12RecruitingLast Updated: March 22, 2012Condition(s): Healthy
- 13WithdrawnLast Updated: January 6, 2011Condition(s): Pulmonary Arterial Hypertension
- 14Active, not recruitingLast Updated: November 12, 2009Condition(s): Adverse Drug Interactions
- 15Active, not recruitingLast Updated: January 3, 2012Condition(s): Osteoarticular Infection
- 16CompletedLast Updated: March 20, 2012Condition(s): Healthy
- 17Not yet recruitingLast Updated: August 2, 2011Condition(s): Tuberculosis
- 18CompletedLast Updated: March 24, 2011Condition(s): Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4; Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Potent Inhibitor of CYP3A4; Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a CYP2C19 Inhibitor.
- 19RecruitingLast Updated: December 5, 2007Condition(s): Scrub Typhus
- 20CompletedLast Updated: October 9, 2008Condition(s): Emesis
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?intr=%22Rifampin%22
